These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 36065707)
41. [Arterial baroreflex--physiological role and assessment of functioning]. Tkaczyszyn M; Rydlewska A; Ponikowska B; Borodulin-Nadzieja L; Banasiak W; Ponikowski P; Jankowska EA Pol Merkur Lekarski; 2013 Aug; 35(206):104-10. PubMed ID: 24052991 [TBL] [Abstract][Full Text] [Related]
42. Abnormal heart rate and blood pressure responses to baroreflex stimulation in multiple sclerosis patients. Sanya EO; Tutaj M; Brown CM; Goel N; Neundörfer B; Hilz MJ Clin Auton Res; 2005 Jun; 15(3):213-8. PubMed ID: 15944871 [TBL] [Abstract][Full Text] [Related]
43. Chronic electroacupuncture of the ST36 point improves baroreflex function and haemodynamic parameters in heart failure rats. Lima JW; Hentschke VS; Rossato DD; Quagliotto E; Pinheiro L; Almeida E; Dal Lago P; Lukrafka JL Auton Neurosci; 2015 Dec; 193():31-7. PubMed ID: 26032957 [TBL] [Abstract][Full Text] [Related]
44. Central exogenous nitric oxide decreases cardiac sympathetic drive and improves baroreflex control of heart rate in ovine heart failure. Ramchandra R; Hood SG; May CN Am J Physiol Regul Integr Comp Physiol; 2014 Aug; 307(3):R271-80. PubMed ID: 24848361 [TBL] [Abstract][Full Text] [Related]
45. Baroreflex activation therapy in the treatment of resistant hypertension. Gordin D; Vikatmaa P; Vikatmaa L; Groop PH; Albäck A; Tikkanen I Duodecim; 2016; 132(20):1874-81. PubMed ID: 29190040 [TBL] [Abstract][Full Text] [Related]
46. First granted example of novel FDA trial design under Expedited Access Pathway for premarket approval: BeAT-HF. Zile MR; Abraham WT; Lindenfeld J; Weaver FA; Zannad F; Graves T; Rogers T; Galle EG Am Heart J; 2018 Oct; 204():139-150. PubMed ID: 30118942 [TBL] [Abstract][Full Text] [Related]
47. Nonpharmacologic Treatment for Heart Failure: A Review of Implantable Carotid Baroreceptor Stimulators As a Therapeutic Option. Malangu B; Lanier GM; Frishman WH Cardiol Rev; 2021; 29(1):48-53. PubMed ID: 32282391 [TBL] [Abstract][Full Text] [Related]
48. Dissociation between ACE activity and autonomic response to ACE inhibition in patients with heart failure. Binkley PF; Nunziata E; Haas GJ; Starling RC; Leier CV; Cody RJ Am Heart J; 2000 Jul; 140(1):34-42. PubMed ID: 10874261 [TBL] [Abstract][Full Text] [Related]
49. Baroreflex activation: from mechanisms to therapy for cardiovascular disease. Iliescu R; Tudorancea I; Lohmeier TE Curr Hypertens Rep; 2014 Aug; 16(8):453. PubMed ID: 24899538 [TBL] [Abstract][Full Text] [Related]
50. Effect of continuous and interval aerobic exercise training on baroreflex sensitivity in heart failure. Masson GS; Borges JP; da Silva PP; da Nóbrega AC; Tibiriçá E; Lessa MA Auton Neurosci; 2016 May; 197():9-13. PubMed ID: 26987408 [TBL] [Abstract][Full Text] [Related]
51. Sympathoactivation and rho-kinase-dependent baroreflex function in experimental renovascular hypertension with reduced kidney mass. Pliquett RU; Benkhoff S; Jung O; Brandes RP BMC Physiol; 2014 Jun; 14():4. PubMed ID: 24946879 [TBL] [Abstract][Full Text] [Related]
52. Deep and future insights into neuromodulation therapies for heart failure. Kishi T J Cardiol; 2016 Nov; 68(5):368-372. PubMed ID: 27293020 [TBL] [Abstract][Full Text] [Related]
53. Patients with continuous-flow left ventricular assist devices provide insight in human baroreflex physiology. Tank J; Heusser K; Malehsa D; Hegemann K; Haufe S; Brinkmann J; Tegtbur U; Diedrich A; Bara C; Jordan J; Strüber M Hypertension; 2012 Sep; 60(3):849-55. PubMed ID: 22824986 [TBL] [Abstract][Full Text] [Related]
54. An early analysis of cost-utility of baroreflex activation therapy in advanced chronic heart failure in Germany. Borisenko O; Müller-Ehmsen J; Lindenfeld J; Rafflenbeul E; Hamm C BMC Cardiovasc Disord; 2018 Aug; 18(1):163. PubMed ID: 30092774 [TBL] [Abstract][Full Text] [Related]
55. Renal and cardiac effects of renal sympathetic denervation and carotid baroreceptor stimulation. Tsioufis C; Dimitriadis K; Thomopoulos C; Doumas M; Papademetriou V; Stefanadis C Curr Vasc Pharmacol; 2014 Jan; 12(1):55-62. PubMed ID: 23905593 [TBL] [Abstract][Full Text] [Related]
56. Modification of autonomic balance by electrical acupuncture does not affect baroreflex dynamic characteristics. Sugimachi M; Kawada T; Yamamoto H; Kamiya A; Miyamoto T; Sunagawa K Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():1981-4. PubMed ID: 19163080 [TBL] [Abstract][Full Text] [Related]
57. A model-based analysis of autonomic nervous function in response to the Valsalva maneuver. Randall EB; Billeschou A; Brinth LS; Mehlsen J; Olufsen MS J Appl Physiol (1985); 2019 Nov; 127(5):1386-1402. PubMed ID: 31369335 [TBL] [Abstract][Full Text] [Related]
58. Exercise training normalizes the blunted central component of the baroreflex in rats with heart failure: role of the PVN. Patel KP; Salgado HC; Liu X; Zheng H Am J Physiol Heart Circ Physiol; 2013 Jul; 305(2):H173-81. PubMed ID: 23686710 [TBL] [Abstract][Full Text] [Related]
59. Carotid Sinus/Nerve Stimulation for Treatment of Resistant Hypertension and Heart Failure. Yin D; Slavin KV Prog Neurol Surg; 2015; 29():83-93. PubMed ID: 26394178 [TBL] [Abstract][Full Text] [Related]
60. Safety and efficacy of baroreflex activation therapy for heart failure with reduced ejection fraction: a rapid systematic review. Schmidt R; Rodrigues CG; Schmidt KH; Irigoyen MCC ESC Heart Fail; 2020 Feb; 7(1):3-14. PubMed ID: 31965746 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]